Menu Search
Equities

LadRx Corp

LADX:QBB

LadRx Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.80
  • Today's Change0.063 / 8.52%
  • Shares traded2.01k
  • 1 Year change+23.08%
  • Beta1.4261
Data delayed at least 15 minutes, as of Nov 22 2024 20:34 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, LadRx Corp increased its cash reserves by 50.55%, or 695.09k. The company earned 1.01m from its operations for a Cash Flow Margin of --. In addition the company paid out 318.81k more in cash than they received while cash form investing activities were even.
Cash flow per share-5.60
Price/Cash flow per share--
Book value per share-3.54
Tangible book value per share-3.54
More ▼

Balance sheet in USDView more

LadRx Corp uses little or no debt in its capital structure.
Current ratio0.0387
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.